Omnicell (OMCL) Shares Outstanding (2010 - 2026)
Omnicell's (OMCL) quarterly Shares Outstanding (Entity) came in at $45.6 million in Q2 2026, down 1.74% year-over-year from $46.4 million in Q2 2025, and little changed quarter-over-quarter from $45.5 million in Q1 2026.
Analysis
Omnicell (OMCL) Shares Outstanding (2010 - 2026) Analysis & Trends
Omnicell (OMCL) has reported Shares Outstanding (Entity) for 17 consecutive years, with $45.6 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Shares Outstanding (Entity) fell 1.74% year-over-year to $45.6 million in Q2 2026; TTM through Jun 2026 was $45.6 million, a 1.74% decrease from a year earlier, with the FY2025 full-year figure at $45.0 million, down 2.92% from the prior year.
- Shares Outstanding (Entity) was $45.6 million for Q2 2026 at Omnicell, roughly flat from $45.5 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $46.8 million in Q1 2025 and troughed at $44.2 million in Q1 2022.
- A 5-year average of $45.4 million and a median of $45.5 million in 2023 frame the typical range for Shares Outstanding (Entity).
- Across the five-year window, Shares Outstanding (Entity) increased 2.32% in 2022 and retreated 3.1% in 2025, its largest moves.
- Over 5 years, Shares Outstanding (Entity) stood at $44.7 million in 2022, then climbed by 1.77% to $45.5 million in 2023, then grew by 1.85% to $46.4 million in 2024, then fell by 2.92% to $45.0 million in 2025, then climbed by 1.3% to $45.6 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $45.6 million (Q2 2026), $45.5 million (Q1 2026), and $45.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 354.10 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 1.28 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 383.50 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 1.47 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 576.40 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 493.20 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 382.20 Mn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | 145.52 Mn |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn | 45.61 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 45.61 Mn |
| Mar 31, 2026 | 45.32 Mn |
| Dec 31, 2025 | 45.97 Mn |
| Sep 30, 2025 | 45.54 Mn |
| Jun 30, 2025 | 46.79 Mn |
| Mar 31, 2025 | 46.60 Mn |
| Dec 31, 2024 | 46.05 Mn |
| Sep 30, 2024 | 46.15 Mn |
| Jun 30, 2024 | 45.95 Mn |
| Mar 31, 2024 | 45.73 Mn |
| Dec 31, 2023 | 45.21 Mn |
| Sep 30, 2023 | 45.33 Mn |
| Jun 30, 2023 | 45.13 Mn |
| Mar 31, 2023 | 44.89 Mn |
| Dec 31, 2022 | 44.40 Mn |
| Sep 30, 2022 | 44.44 Mn |
| Jun 30, 2022 | 44.22 Mn |
| Mar 31, 2022 | 44.25 Mn |
| Dec 31, 2021 | 43.48 Mn |
| Sep 30, 2021 | 43.65 Mn |